JU YEON PYO

Dr. JU YEON PYO

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2019 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
JSJa Yeong Seo
Ja Yeong Seo
JPJi-Hyun Park
Ji-Hyun Park
JPJU YEON PYO
JU YEON PYO
Yoon Jin ChaYoon Jin Cha
Yoon Jin Cha
Chan Kwon JungChan Kwon Jung
Chan Kwon Jung
SHSoon Won Hong
Soon Won Hong
In the present multi-institutional study, the prevalence and clinicopathologic characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) were evaluated among Korean patients who underwent thyroidectomy for papillary thyroid carcinoma (PTC). Data from 18,819 patients with PTC from eight university hospitals between January 2012 and February 2018 were retrospectively evaluated. Pathology reports of all PTCs and slides of potential NIFTP cases were reviewed. The strict criterion of no papillae was applied for the diagnosis of NIFTP. Due to assumptions regarding misclassification of NIFTP as non-PTC tumors, the lower boundary of NIFTP prevalence among PTCs was estimated. Mutational analysis for BRAF and three RAS isoforms was performed in 27 randomly selected NIFTP cases. The prevalence of NIFTP was 1.3% (238/18,819) of all PTCs when the same histologic criteria were applied for NIFTP regardless of the tumor size but decreased to 0.8% (152/18,819) when tumors ≥1 cm in size were included. The mean follow-up was 37.7 months and no patient with NIFTP had evidence of lymph node metastasis, distant metastasis, or disease recurrence during the follow-up period. A difference in prevalence of NIFTP before and after NIFTP introduction was not observed. BRAFV600E mutation was not found in NIFTP. The mutation rate for the three RAS genes was 55.6% (15/27). The low prevalence and indolent clinical outcome of NIFTP in Korea was confirmed using the largest number of cases to date. The introduction of NIFTP may have a small overall impact in Korean practice.

15 November 2024 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
JPJU YEON PYO
JU YEON PYO
Yoon Jin ChaYoon Jin Cha
Yoon Jin Cha
SHSoonWon Hong
SoonWon Hong
Background: Radioiodine (RI) ablation following thyroid-stimulating hormone suppression is an effective treatment for papillary thyroid cancer (PTC), typically leading to favorable outcomes. However, RI-refractory tumors exhibit aggressive behavior and poor prognoses. Recent studies highlight the role of genetic abnormalities in PTC signaling pathways, including the activation of telomerase reverse transcriptase (TERT), and the correlation of mutations with adverse outcomes. Methods: This study analyzed mutations in BRAF V600E and the TERT-promoter genes, comparing clinicopathological features between RI-refractory and RI-responsive PTCs. Among 82 RI-refractory patients, formalin-fixed, paraffin-embedded tissues from initial surgeries were available for 26. Another 89 without distant metastasis over 5 years formed a matched RI-responsive control group. Results: Histopathologically, RI-refractory PTCs showed increased frequencies of small tumor clusters without fibrovascular cores, hobnail features, and a high height-to-width ratio of tumor cells. These tumors were more likely to exhibit necrosis, mitosis, lymph node metastasis, extrathyroidal extension, and involvement of resection margins. TERT-promoter mutations were statistically significantly associated with these aggressive clinicopathologic features. Immunohistochemically, decreased expression of sodium iodide symporter and thyroglobulin stimulating hormone receptor proteins was common in RI-refractory PTCs, along with lower levels of oncogenic proteins such as vascular endothelial cell growth factor, vascular endothelial cell growth factor receptor 2, and nuclear factor kappa-light-chain-enhancer of activated B cells. Total loss of PTEN expression was occasionally observed. In contrast, all cases tested positive for cytoplasmic β-catenin. Conclusions: RI-refractory PTCs are linked to TERT mutations and exhibit specific aggressive histopathologic features, particularly in tumor centers.

15 November 2018 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
HCHyunseo Cha
Hyunseo Cha
JPJU YEON PYO
JU YEON PYO
SHSoon Won Hong
Soon Won Hong
Fine-needle aspiration cytology serves as a safe, economical tool in evaluating thyroid nodules. However, about 30% of the samples are categorized as indeterminate. Hence, many immunocytochemistry markers have been studied, but there has not been a single outstanding marker. We studied the efficacy of CD56 with human bone marrow endothelial cell marker-1 (HBME-1) in diagnosis in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) category III. We reviewed ThinPrep liquid-based cytology (LBC) samples with Papanicolaou stain from July 1 to December 31, 2016 (2,195 cases) and selected TBSRTC category III cases (n = 363). Twenty-six cases were histologically confirmed as benign (six cases, 23%) or malignant (20 cases, 77%); we stained 26 LBC slides with HBME-1 and CD56 through the cell transfer method. For evaluation of reactivity of immunocytochemistry, we chose atypical follicular cell clusters. CD56 was not reactive in 18 of 20 cases (90%) of malignant nodules and showed cytoplasmic positivity in five of six cases (83%) of benign nodules. CD56 showed high sensitivity (90.0%) and relatively low specificity (83.3%) in detecting malignancy (p = .004). HBME-1 was reactive in 17 of 20 cases (85%) of malignant nodules and was not reactive in five of six cases (83%) of benign nodules. HBME-1 showed slightly lower sensitivity (85.0%) than CD56. The specificity in detecting malignancy by HBME-1 was similar to that of CD56 (83.3%, p = .008). CD56 and HBME-1 tests combined showed lower sensitivity (75.0% vs 90%) and higher specificity (93.8% vs 83.3%) in detecting malignancy compared to using CD56 alone. Using CD56 alone showed relatively low specificity despite high sensitivity for detecting malignancy. Combining CD56 with HBME-1 could increase the specificity. Thus, we suggest that CD56 could be a useful preoperative marker for differential diagnosis of TBSRTC category III samples.

9 September 2024 in Materials
Verified
Journal Article
Open access
PDF file
SHSung Ok Hong
Sung Ok Hong
JPJU YEON PYO
JU YEON PYO
SOSung Woon On
Sung Woon On
JSJa-Yeong Seo
Ja-Yeong Seo
JCJin-Young Choi
Jin-Young Choi
The purpose of this study was to investigate the optimization of computer-aided design/computer-aided manufacturing (CAD/CAM) patient-specific implants for mandibular facial bone defects and compare the biocompatibility and osseointegration of machined titanium (Ma), Sandblasted/Large-grit/Acid-etched (SLA) titanium, and polyetherketoneketone (PEKK) facial implants. We hypothesized that the facial implants made of SLA titanium had superior osseointegration when applied to the gonial angle defect and prevented the senile atrophy of the bone. Histologic findings of the soft-tissue reaction, hard-tissue reaction, and bone–implant contact (BIC (%) of 24 Ma, SLA, and PEKK facial implants at 8 and 12 weeks were investigated. There was no statistical difference in the soft tissue reaction. Bone was formed below the periosteum in all facial implants at 12 weeks and the BIC values were significantly different at both 8 and 12 weeks (p < 0.05). Ma, SLA, and PEKK facial implants are biocompatible with osseointegration properties. SLA can enhance osseointegration and provoke minimal soft tissue reactions, making them the most suitable choice. They provide an excellent environment for bone regeneration and, over the long term, may prevent atrophy caused by an aging mandible. The bone formation between the lateral surface of the facial implant and periosteum may assist in osseointegration and stabilization.

11 December 2024 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
JPJU YEON PYO
JU YEON PYO
NJNara Jeon
Nara Jeon
SSSu-Jin Shin
Su-Jin Shin
MJMinsun Jung
Minsun Jung
BLBeom Jin Lim
Beom Jin Lim
RPRenal Pathology Study Group of Korean Society of Pathologists
Renal Pathology Study Group of Korean Society of Pathologists
Lupus nephritis is well-known for low concordance in classification. Furthermore, there has been no agreement analysis among Korean renal pathologists regarding lupus nephritis. Inconsistent diagnosis leads to confusion and increases medical costs, as well as failure of appropriate therapeutic interventions. This study aimed to assess the level of agreement among Korean renal pathologists regarding classification. Representative glomerular images from patients diagnosed with lupus nephritis were obtained from five hospitals. Twenty-five questions were formulated, and multiple-choice questions with 14 options, consisting of characteristic histopathological findings of lupus nephritis were provided. Three rounds of surveys were conducted and educational sessions were conducted before the second and third surveys. The agreement was calculated using Fleiss' κ and the means for each round of questions were as follows: Survey 1, 0.42 (range, 0.18-0.61), Survey 2, 0.42 (range, 0.19-0.64), and Survey 3, 0.47 (range, 0.23-0.65). Although κ after the first education session showed no significant difference compared to the initial κ (p = 0.95), after the second education session, κ increased significantly compared to the initial κ (p < 0.001). The κ for each item generally increased with each education session, but they were not statistically significant (p = 0.46, p = 0.17). Additionally, the rankings of agreement, for each item, were relatively consistent. This study conducted an interobserver agreement analysis of Korean pathologists for lupus nephritis, with the goal of increasing agreement through education. Although the education increased overall agreement, items like "mesangial hypercellularity," "endocapillary hypercellularity," and "neutrophils and/or karyorrhexis" remained inconsistent attributable to innate subjectivity and ineffective education.

9 July 2024
Verified
Book Chapter
Open access
PDF file
SSSu-Jin Shin
Su-Jin Shin
JPJU YEON PYO
JU YEON PYO
SHSoonWon Hong
SoonWon Hong
'Correction to: Diagnosis of Follicular Neoplasm' published in 'Thyroid FNA Cytology'